Andrea Tam promoted to Chief Commercial Officer (CCO)
Following a corporate restructuring and the streamlining of operations at Cerbios-Pharma SA (from now on CERBIOS), we are proud to announce the promotion of Andrea Tam to the position of Chief Commercial Officer (CCO).
Andrea Tam will lead the newly created Commercial Business Unit, which includes both divisions: Chemical and Biological.
The four teams that were directly reporting to the CEO, two Business Development and two Marketing & Sales, will now report to him directly. In his new role he will be responsible for all commercial activities, from early stage to commercial supply as well as customer services.
Andrea Tam will report directly to Gabriel Haering (CEO) and will, however, continue his current activities as Director Business Development.
“This structural change was required due to company growth and the increasing complexity of commercial relations in the different geographic areas where Cerbios is active.” says Gabriel Haering, CEO.
“This is also part of the long-term organizational strategy of CERBIOS, that integrates all our activities in a leaner structure, creating value for our partners”.
Mr. Tam holds a degree in industrial chemistry from the Università degli Studi di Milano and has been active in the pharmaceutical industry since 1998.
After a period as research associate at the University he joined in 2000 the Italian subsidiary of Mitsubishi Chemical Corporation Group as R&D scientist achieving the position of R&D Manager.
In 2005, he joined Antibioticos Marketing & Sales Department managing special projects and custom projects with key accounts.
His career continued between 2007 and 2012 with Recordati S.p.A. as Manager Business Development in the Pharmaceutical Chemicals Division with world-wide responsibility and then as BD Manager at Farmabios.
He joined CERBIOS on May 14th 2012 as Director Business Development taking care of Cerbios’ contract manufacturing activities.
About Cerbios-Pharma SA
Cerbios is a privately held company located in Lugano (Switzerland) specialized in the development and manufacturing of chemical and biological APIs for our partners world-wide. APIs made by Cerbios cover small molecules (Chemical Division), large molecules and Probiotics (Biological Division).
Services for third parties under exclusive manufacturing are offered in the area of HPAIs for the Chemical Division and Recombinant Proteins or monoclonal Antibodies for the Biological Division.
Full CMC support is provided to our partners world-wide in order to supply them with cGMP clinical batches, registration/validation material, and APIs from commercial manufacturing. Paramount to this is the ability to supply all the documentation required for a successful registration.
Cerbios is selling commercial products mainly in Europe, USA,Japan and India.
Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacture of both chemical and biological APIs for its partners world-wide.
Exclusive, third-party manufacturing services are offered by the Chemical Division for HPAIs and by the Biological Division for monoclonal antibodies, recombinant proteins and pharma probiotics.
Cerbios provides full CMC support to its world-wide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA, Japan and India.